StageZero Life Sciences Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of StageZero Life Sciences Ltd. generated cash of -$3,528,756, which is more than the previous year. Cash used in financing activities reached the amount of $1,832,726 last year. Net change in cash is therefore -$1,709,040.
Cash Flow
| 2013 | -4.33M | 222.39K | -459.99K |
|---|---|---|---|
| 2014 | -1.53M | -4.64M | 6.00M |
| 2015 | -1.72M | -2.57M | 2.45M |
| 2016 | -3.68M | -33.98K | 3.41M |
| 2017 | -3.82M | 0 | 3.65M |
| 2018 | -3.29M | -2.79K | 3.35M |
| 2019 | -4.59M | -33.37K | 4.58M |
| 2020 | -3.06M | -72.31K | 9.66M |
| 2021 | -8.95M | -20.96K | 4.10M |
| 2022 | -3.52M | 0 | 1.83M |
SZLS.TO Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.72M | 6.59M | 71.12K | 106.22K | 41.22K | 213.84K | 515.59K | 2.33M | 2.54M | 7.28M |
Operating activities | ||||||||||
Net income | -11.41M | -7.48M | -6.86M | -3.48M | -3.94M | -2.94M | -5.91M | -6.01M | -6.61M | -8.83M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 437.44K | 509.27K | 216.33K | 298.08K | 310.80K | 347.38K | 341.74K | 4.26K | 15.54K | 275.62K |
Stock-based compensation expense | 238.50K | 390.94K | 636.74K | 741.45K | 0 | 392.03K | 512.12K | 376.77K | 890.83K | 714.92K |
| Deferred income tax benefit | 238.50K | 390.94K | 636.74K | 741.45K | 0 | 392.03K | 512.12K | 376.77K | 890.83K | 714.92K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 95.65K | -52.94K | -52.25K | 23.40K | 10.77K | 31.02K | -63.48K | 494.24K | -405.35K | 0 |
Inventories | 313.18K | -53.80K | -267.25K | 23.21K | -25.30K | 13.15K | 81.84K | 0 | 0 | 0 |
Accounts payable | 0 | -323.81K | 52.25K | -23.40K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -3.52M | -8.95M | -3.06M | -4.59M | -3.29M | -3.82M | -3.68M | -1.72M | -1.53M | -4.33M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.64M | 0 |
Investments In Property Plant And Equipment | 0 | -148.22K | -72.31K | -44.37K | -2.79K | 0 | 0 | -771 | -3.54K | -535.60K |
Acquisitions Net | 0 | 80.78K | 0 | 0 | 0 | 0 | -33.98K | -2.57M | 0 | 0 |
Cash generated by investing activities | 0 | -20.96K | -72.31K | -33.37K | -2.79K | 0 | -33.98K | -2.57M | -4.64M | 222.39K |
Financing activities | ||||||||||
Common Stock Issued | 1.54M | 3.10M | 9.55M | 3.94M | 1.05M | 1.73M | 2.10M | 963.31K | 6.21M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 290.17K | -404.39K | -401.41K | 648.56K | -110K | 2.02M | -255.91K | 400K | -244.96K | -410.88K |
Cash used in financing activities | 1.83M | 4.10M | 9.66M | 4.58M | 3.35M | 3.65M | 3.41M | 2.45M | 6.00M | -459.99K |
Net Change In Cash | -1.70M | -4.87M | 6.52M | -35.10K | 65.00K | -172.61K | -301.75K | -1.82M | -207.96K | -4.51M |
Cash at end of period | 15.68K | 1.72M | 6.59M | 71.12K | 106.22K | 41.22K | 213.84K | 515.59K | 2.33M | 2.77M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |